Kawada Hiroshi

論文

Clinicopathological and transcriptomic profiles of 101 patients with diffuse large B-cell lymphoma/high-grade B-cell lymphoma with double-hit MYC and BCL2 or BCL6 and triple hit.

Improvement in anemia and symptoms after switching from crovalimab to iptacopan in paroxysmal nocturnal hemoglobinuria

Redefining the Spectrum of Epstein-Barr Virus–Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin Lymphoma

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review

Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.

Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma.

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

ALK-negative anaplastic large cell lymphoma with TP53 mutation developing during the administration of baricitinib for atopic dermatitis - A case report.

Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.

Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation.

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report.

[Disseminated toxoplasmosis after cord blood transplantation diagnosed at autopsy].

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax.

HIF-PH阻害薬ダプロデュスタットは低トランスフェリン飽和度の骨髄異形成症候群の造血不全を改善する

共同研究・競争的資金等の研究課題

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.

Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.

Development of a novel low-invasive treatment against acute leukemia adopting enhancement of oxidative stress

Subacute phase-cytokine therapy for the regeneraton of infarcted brain tissue

Myocardial Regeneration by Cytokine-mobilized Bone Marrow Stem Cells

Human hematopoietic reconstitution bu a single hematopoietic stem cell using intra-bone marrow transplantation

Cell therapy using bone marrow-derived stem cells, the possibility of its application in regenerative medicine.

In vitro expension of hematopoietic stem cells

Flow cytometric analysis in hematological malignancies